NEW YORK (GenomeWeb News) – The Neurodegeneration Consortium this week said that it has received a commitment of $5 million from the Huffington Foundation to help fund the consortium's genomics-based work in Alzheimer's disease and other neurodegenerative disorders.

The gift will go toward NDC's research using genomic technology to identify new molecular targets to treat neurodegenerative diseases. NDC collaborators are inhibiting and interrogating thousands of genes, one at a time, in order to identify those that may decrease the levels of proteins that cause disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.